TMCnet News
Entasis Therapeutics to Present at the BMO Capital Markets 2018 Prescriptions for Success Healthcare ConferenceWALTHAM, Mass., Dec. 05, 2018 (GLOBE NEWSWIRE) -- Entasis Therapeutics (NASDAQ: ETTX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial products, announced that Manos Perros, President and Chief Executive Officer, will present at the BMO Capital Markets 2018 Prescriptions for Success Healthcare Conference in New York, NY. Event: BMO Capital Markets 2018 Prescriptions for Success Healthcare Conference A live webcast of the presentation can be accessed under "Investors & Media" in the “News & Events” section of the Company's website at www.entasistx.com. About Entasis Company Contact Investor Contact Media Contact |